CDC: Falls Leading Cause of Injury, Death in U.S. Seniors

Share this content:
CDC: Falls Leading Cause of Injury, Death in U.S. Seniors
CDC: Falls Leading Cause of Injury, Death in U.S. Seniors

THURSDAY, Sept. 22, 2016 (HealthDay News) -- Falls are the leading cause of injury and death among older people in the United States, according to research published in the Sept. 23 issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.

Researchers from the CDC analyzed data from the 2014 Behavioral Risk Factor Surveillance System survey. The scope of the study was limited to older adults (age 65+) in all 50 states and the District of Columbia who were asked questions about falls.

In 2014, 28.7 percent of respondents reported falling at least once in the preceding 12 months, resulting in an estimated 29 million falls. Of those reporting falls, 37.5 percent reported at least one fall requiring medical treatment or activity restriction for at least one day, an estimated 7.0 million fall injuries. Falls cost Medicare an estimated $31.3 billion a year.

"Older adult falls are increasing and, sadly, often herald the end of independence," Tom Frieden, M.D., M.P.H., director of the CDC, said in an agency news release. "Health care providers can make fall prevention a routine part of care in their practice, and older adults can take steps to protect themselves."

Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

Insulin Glargine, Lixisenatide Combo Beneficial in T2DM

Insulin Glargine, Lixisenatide Combo Beneficial in T2DM

Improved achievement of glycemic targets, reduced body weight

European, American Guidelines Lead to Different Recs for Statins

European, American Guidelines Lead to Different Recs for ...

Quantification of CAC score can improve stratification for those at high, low risk for events

Hyperbaric O2 Therapy Effective in Maxillary Osteoradionecrosis

Hyperbaric O<sub>2</sub> Therapy Effective in Maxillary Osteoradionecrosis

Positive clinical outcome with HBOT for 85.7 percent of patients with maxillary bone osteoradionecrosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »